-
Professor Jia Wei’s Team: Exceptional Efficacy of Dual-Targeted CD19/20 CAR-T Therapy in Treating Relapsed/Refractory B-Cell Lymphoma Patients
The 29th Annual Meeting of the European Hematology Association (EHA) was grandly held in Madrid, Spain, from June 13 to 16, 2024. As the largest international conference in the field of hematology in Europe, it annually attracts experts and scholars from around the world to share and discuss innovative ideas and the latest scientific and…
-
EHA Expert Interview with Professor Yang Liang: Immune-Based Insights into Secondary Resistance to Anti-CD38 Therapy in Multiple Myeloma
The 29th Annual Meeting of the European Hematology Association (EHA) was held from June 13 to 16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world to share and discuss innovative ideas and the latest scientific and clinical research…
-
EHA China Voice丨Professor Liang Wang’s Team: Exploring Optimal Treatment for Vitreoretinal Lymphoma
The 29th Annual Meeting of the European Hematology Association (EHA) was grandly held from June 13 to 16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world every year to share and discuss innovative ideas and the latest scientific…
-
Prof. Yue Lu’s Team Compares ATG-T vs. ATLG in TBI-Based Conditioning for Alternative Donor Allogeneic Hematopoietic Stem Cell Transplantation
The 29th Annual Meeting of the European Hematology Association (EHA) was held from June 13 to 16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world each year to share and discuss innovative ideas and the latest scientific and…
-
EHA-CSH Joint Symposium: Professor Jianxiang Wang on Sino-European Hematology Exchange and Future Development
The 29th Annual Congress of the European Hematology Association (EHA) took place from June 13 to 16, 2024, in Madrid, Spain. Renowned as the “Olympics” of European hematology, the EHA Congress is celebrated for its cutting-edge scientific discussions and extensive clinical research findings, drawing global attention. Among the numerous highlights of this year’s event was…
-
Preview of APACC 2024丨Dr. Shenglan Tang: Implementation and Policy of HPV Vaccination
The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2024 will be held in Hong Kong as a hybrid conference on 27-29 June 2024. During Parallel Session 5: Women’s Health – HPV, Professor Shenglan Tang from Duke Kunshan University will deliver a presentation titled “Implementation / Policy of HPV Vaccination”.
-
EASL Expert Interview | Professor Fengmin Lu: From Mechanistic Research to Clinical Cure – Exploring Potential Treatment Strategies for CHB
In the field of chronic HBV infection, the discovery of basic core promoter (BCP) and pre-core (PC) mutations dates back nearly thirty years. However, the potential link between these mutations and the progression of chronic hepatitis B (CHB), as well as their impact on antiviral treatment response, has been a focal point for virologists for…
-
Preview of APACC 2024丨Dr. Owen Tsang: Real-World Experience of Long-Acting ARVs
The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2024 will be held in Hong Kong as a hybrid conference on 27-29 June 2024. During Parallel Session 9: Long-acting ARV, Dr. Owen Tsang from Princess Margaret Hospital will deliver a presentation titled “Real-World Experience – Hong Kong”. In this e-mail interview with “Infectious Disease Frontier” on the…
Connecting Medical Expertise through Media